|
Description |
SSPA Code |
Issuer |
Underlying |
Ccy |
Issue Price |
Coupon/ Max Yld |
Barrier |
Feature |
Maturity |
Valor |
End of Subscription |

|
8.00% p.a. on Multi Shares |
1220 |
Credit Suisse International, London |
JPMorgan Chase / Halliburton / Apple |
USD |
100% |
8% |
|
Trigger |
30.07.2014 (1.5yrs) |
20260573 |
23.01.2013 (9 days left) |

|
8.00% p.a. on BRIC Indices |
1230 |
Credit Suisse International, London |
iShares MSCI Brazil / Russian Depositary / DBIX India / Hang Seng China Enterprise |
USD |
100% |
8% |
55% |
Callable |
29.07.2014 (1.5yrs) |
20260571 |
22.01.2013 (8 days left) |

|
5.20% p.a. on Gold / Silver / Palladium / Platinum |
1230 |
Credit Suisse International, London |
Gold / Silver / Palladium / Platinum |
CHF |
100% |
5.2% |
59% |
|
30.01.2015 (2yrs) |
20260575 |
22.01.2013 (8 days left) |

|
6.50% p.a. on Gold / Silver / Palladium / Platinum |
1230 |
Credit Suisse International, London |
Gold / Silver / Palladium / Platinum |
USD |
100% |
6.5% |
59% |
|
30.01.2015 (2yrs) |
20260576 |
22.01.2013 (8 days left) |

|
8.00% on Rio Tinto / BHP Billiton / Vale |
1230 |
Credit Suisse AG, London Branch |
Rio Tinto / BHP Billiton / Vale |
CHF |
100% |
8% |
65% |
|
23.01.2014 (1yr) |
20214516 |
18.01.2013 (4 days left) |

|
8.00% on Citigroup / Bank of America / Goldman Sachs |
1230 |
Credit Suisse AG, London Branch |
Citigroup / Bank of America / Goldman Sachs |
USD |
100% |
8% |
59% |
|
24.01.2014 (1yr) |
20214515 |
18.01.2013 (4 days left) |

|
7.50% p.a. on Syngenta / Monsanto / Potash |
1230 |
Credit Suisse AG, London Branch |
Syngenta / Monsanto / Potash |
CHF |
100% |
7.5% |
69% |
|
23.07.2014 (1.5yrs) |
20214517 |
18.01.2013 (4 days left) |

|
7.25% p.a. on Holcim / Swiss Re / ABB |
1230 |
Credit Suisse AG, London Branch |
Holcim / Swiss Re / ABB |
CHF |
100% |
7.25% |
65% |
|
22.07.2014 (1.5yrs) |
19279633 |
17.01.2013 (3 days left) |

|
6.50% p.a. on Nestlé / Swatch / Swiss Re |
1230 |
Credit Suisse AG, London Branch |
Nestlé / Swatch / Swiss Re |
CHF |
100% |
6.5% |
59% |
|
22.01.2015 (2yrs) |
20214513 |
17.01.2013 (3 days left) |

|
7.25% on Royal Dutch Shell / Unilever / Daimler |
1230 |
Credit Suisse AG, London Branch |
Royal Dutch Shell / Unilever / Daimler |
EUR |
100% |
7.25% |
69% |
|
22.01.2014 (1yr) |
20214514 |
17.01.2013 (3 days left) |

|
7.75% on Tiffany & Co. / Ralph Lauren / LVMH |
1230 |
Credit Suisse AG, London Branch |
Tiffany & Co. / Ralph Lauren / LVMH |
USD |
100% |
7.75% |
59% |
|
23.01.2014 (1yr) |
19279632 |
17.01.2013 (3 days left) |

|
8.10% p.a. on Brent Crude Oil |
1230 |
Credit Suisse International, London |
Brent Crude Oil |
USD |
100% |
8.1% |
75% |
Callable |
24.07.2013 (0.5yrs) |
20260572 |
17.01.2013 (3 days left) |

|
7.25% on Credit Suisse Group |
1230 |
Credit Suisse AG, London Branch |
Credit Suisse Group |
CHF |
100% |
7.25% |
69% |
|
21.01.2014 (1yr) |
19279629 |
16.01.2013 (2 days left) |

|
8.00% p.a. on Syngenta / Holcim / Richemont |
1230 |
Credit Suisse AG, London Branch |
Syngenta / Holcim / Richemont |
CHF |
100% |
8% |
69% |
|
21.07.2014 (1.5yrs) |
19279630 |
16.01.2013 (2 days left) |

|
7.40% p.a. on SMI® / EURO STOXX 50® / S&P 500® / Nikkei |
1230 |
Credit Suisse AG, London Branch |
SMI® / EURO STOXX 50® / S&P 500® / Nikkei |
USD |
100% |
7.4% |
60% |
Callable |
26.01.2015 (2yrs) |
19036663 |
16.01.2013 (2 days left) |

|
6.30% p.a. on SMI® / EURO STOXX 50® / S&P 500® / Nikkei |
1230 |
Credit Suisse AG, London Branch |
SMI® / EURO STOXX 50® / S&P 500® / Nikkei |
EUR |
100% |
6.3% |
60% |
Callable |
26.01.2015 (2yrs) |
19036662 |
16.01.2013 (2 days left) |

|
6.25% p.a. on SMI® / EURO STOXX 50® / S&P 500® / Nikkei |
1230 |
Credit Suisse AG, London Branch |
SMI® / EURO STOXX 50® / S&P 500® / Nikkei |
CHF |
100% |
6.25% |
60% |
Callable |
26.01.2015 (2yrs) |
19036661 |
16.01.2013 (2 days left) |

|
6.25% p.a. on Novartis / Bayer / Merck & Co. |
1230 |
Credit Suisse AG, London Branch |
Novartis / Bayer / Merck & Co. |
CHF |
100% |
6.25% |
65% |
|
21.07.2014 (1.5yrs) |
19279628 |
16.01.2013 (2 days left) |

|
5.50% on Nestlé / Roche / Novartis |
1230 |
Credit Suisse AG, London Branch |
Nestlé / Roche / Novartis |
CHF |
100% |
5.5% |
79% |
|
20.01.2014 (1yr) |
19279627 |
15.01.2013 (1 day left) |

|
7.25% on Caterpillar / Deere & Co / General Electric |
1230 |
Credit Suisse AG, London Branch |
Caterpillar / Deere & Co / General Electric |
USD |
100% |
7.25% |
65% |
|
21.01.2014 (1yr) |
19279626 |
15.01.2013 (1 day left) |

|
8.50% p.a. on Bayer / Siemens / BMW |
1230 |
Credit Suisse AG, London Branch |
Bayer / Siemens / BMW |
EUR |
100% |
8.5% |
65% |
|
17.07.2014 (1.5yrs) |
19279625 |
14.01.2013 (today) |
|
This message may contain confidential, proprietary or legally privileged information and is intended
only for the use of the addressee named above. No confidentiality or privilege is waived or lost by
any misstransmission. If you are not the intended recipient of this message you are hereby notified
that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you
have received this message in error please delete it and any copies of it and notify the sender immediately.
Credit Suisse Group AG and its subsidiaries reserve the right to retain, intercept and monitor any e-mail
communication through its networks if legally allowed.
This document was produced by Credit Suisse AG and/or its affiliates (hereafter "CS") with the greatest
of care and to the best of its knowledge and belief. Credit Suisse provides no guarantee with regard to
its content and completeness and does not accept any liability for losses which might arise from making
use of this information.
This document does not constitute an offer or a recommendation to buy or sell financial instruments or
banking services; the relevant terms and conditions are described in the sales prospectus and summarized
in the simplified prospectus in accordance with CISA. We recommend to request prior to an investment
decision the complete product information, especially with respect to product specific risks, prices and
fees or charges. The product information can be obtained free of charge under the telephone number mentioned
herein. The prospectus requirements of Art. 652a / Art. 1156 of the Swiss Code of Obligations are not applicable.
Structured products are suitable only for investors who understand how they work and, in particular, the
associated risks, and who are able to bear their financial consequences. Investors are exposed to issuer
risk. The structured product's retention of value is dependent not only on the development of the value
of the underlying asset, but also on the creditworthiness of the Issuer, which may change over the term
of the structured product.
These structured products may include investments in indices:
The underlying indices are registered trademarks and have been licensed for use (SIX Swiss Exchange as
licensor for Swiss Market Index (SMI)®; McGraw-Hill Companies Inc. as licensor for S&P 500® Index;
STOXX Limited Zurich as licensor for EURO STOXX 50® Index; Nikkei Inc. as licensor for Nikkei 225®
Index; Deutsche Börse AG as licensor for DAX® Index and Euronext Paris S.A. as licensor for CAC 40® Index).
The indices are compiled and calculated solely by licensors and the licensors shall have no liability
with respect thereto. The products based on the indices are in no way sponsored, endorsed, sold or
promoted by the licensors.
These structured products may include investments in Emerging Markets:
Emerging Markets are located in countries that possess one or more of the following characteristics:
A certain degree of political instability, relatively unpredictable financial markets and economic growth
patterns, a financial market that is still at the development stage or a weak economy. Emerging markets
investments usually result in higher risks such as political risks, economical risks, credit risks,
exchange rate risks, market liquidity risks, legal risks, settlement risks, market risks, shareholder
risk and creditor risk.
These structured products may include investments in commodities:
Commodity investments are subject to greater fluctuations in value than normal investments and may lead to
additional investment risks.
Neither the information provided on this website may not be sent, taken into or distributed in the
United States or to any U. S. person (within the meaning of Regulation S under the US Securities
Act of 1933, as amended). This document may not be reproduced either in part or in full without
the written permission of Credit Suisse.
*We would like to draw your attention to the fact that telephone calls to our lines are recorded.
When we receive your call, we assume that you accept this business practice.
Copyright © 2013 Credit Suisse Group AG and/or its affiliates. All rights reserved.
|